Whalesbook
AI 'Brain' Drives Practo's Growth
Practo's achievement of over $100 million in gross merchandise value (GMV) is largely thanks to its advanced AI systems. These AI tools go beyond simple transactions, actively guiding patients to find care and make informed decisions. Every day, more than 20,000 AI-driven interactions quickly deliver important healthcare information, crucial where delays can matter. This system is the foundation for Practo's goal: to create a central 'AI brain' for healthcare, offering a seamless, guided experience for patients and doctors instead of a disjointed one. The company is hiring more AI engineers to build this intelligence directly into healthcare processes.
Practo's Market Position and Rivals
Practo leads India's online doctor consultation market, holding an estimated 35% share with a network of over 150,000 verified doctors and 80,000 facilities. AI upgrades in 2025 reportedly boosted efficiency by about 30%. Practo offers doctor discovery, teleconsultations, and surgery services, setting it apart from rivals like PharmEasy or Netmeds, which focus more on pharmacy or diagnostics. Competitors such as MediBuddy and Apollo 24/7 offer similar integrated care, but Practo's focus on a comprehensive 'AI brain' aims to provide unique global support for healthcare decisions based on data. Financially, Practo reported 22% revenue growth in FY24 and cut annual losses by 90%. The company also achieved EBITDA-positive results in Q4 FY24, indicating stronger financial health.
Challenges and Criticisms Facing Practo
Practo faces significant challenges despite its strong market position. Competition from major healthcare chains and large online pharmacies launching their own platforms could threaten its market share, especially as data becomes more standardized. Telemedicine and e-pharmacy regulations are also evolving, creating compliance hurdles. Some healthcare providers have raised concerns about Practo's data transparency, fake testimonials, and commission rates, indicating possible issues within its network. For instance, rivals like Doccure provide clinics with full brand control and clear pricing, which some doctors feel is a better alternative to Practo's shared marketplace that might dilute their brand. With Practo looking towards a potential public listing, its ownership is increasingly with institutional investors. These investors expect profitability and strong financial performance, putting Practo's operational efficiency and competitive weaknesses under scrutiny. While losses have decreased, the path to sustained profitability remains a key focus.
Global Expansion and Future Outlook
Practo's aim to build a unified AI system as its 'AI brain' fits with the booming AI in healthcare market, projected to exceed $1 trillion by 2034 with nearly 44% annual growth. The company is expanding into the US, where it has reportedly signed up over 200,000 doctors and gained more than 300,000 monthly active users in certain areas, showing its potential for international reach. Practo is investing heavily in AI engineers and has a clear plan for AI-driven healthcare processes, aiming to become a vital intelligence provider beyond just a marketplace. Its recent financial improvements, including lower losses and revenue growth, along with talks about pre-IPO funding, suggest a move to increase revenue and company value. This could lead to an IPO or a strategic sale in the coming years.